Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

Follistatin-Like Protein 1 Promotes Arthritis by Up-Regulating IFN- 

(2014) S. D. Clutter et al.   JOURNAL OF IMMUNOLOGY

Follistatin-Like 1 in Chronic Systolic Heart Failure

(2011) Ali El-Armouche et al.   Circulation-Heart Failure

Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy

(2011) Masayuki Shimano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis

(2011) Marc Sylva et al.   PLoS One

Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development

(2011) Y. Geng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart

(2011) Shirin Doroudgar et al.   TRENDS IN MOLECULAR MEDICINE

Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis

(2011) Dawei Li et al.   ARTHRITIS RESEARCH & THERAPY

Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis

(2010) David C. Wilson et al.   ARTHRITIS AND RHEUMATISM

Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure

(2010) Joerg Heineke et al.   CIRCULATION

DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1 - analysis of their binding with TGF-β superfamily proteins

(2010) Masao Tanaka et al.   FEBS Journal

DIP2A Functions as a FSTL1 Receptor

(2010) Noriyuki Ouchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

(2010) Masayuki Shimano et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury

(2009) Yuichi Oshima et al.   CIRCULATION

Circulating Concentrations of Follistatin-Like 1 in Healthy Individuals and Patients with Acute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay

(2009) C. Widera et al.   CLINICAL CHEMISTRY

Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction

(2009) Yasumasa Ikeda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An Immunomodulatory Role for Follistatin-Like 1 in Heart Allograft Transplantation

(2008) J. B. Le Luduec et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis—a differential expression and functional analysis

(2008) Queeny K.Y. Chan et al.   CARCINOGENESIS

Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart

(2008) Yuichi Oshima et al.   CIRCULATION

Expression of Follistatin-Related Genes Is Altered in Heart Failure

(2008) Enrique Lara-Pezzi et al.   ENDOCRINOLOGY

AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice

(2008) Ping Zhang et al.   HYPERTENSION

Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt

(2008) Anita Y. M. Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism

(2008) Noriyuki Ouchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart

(2008) Edward J. Miller et al.   NATURE